Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)

SYGNIS AG develops and commercialises value-added, easy-to-use, reliable products based on its proprietary technologies, offering a wide range of solutions that address key challenges in molecular biology. With the acquisitions of Expedeon Holdings, Ltd. in 2016 and both C.B.S. Scientific Company, Inc. and Innova Biosciences Ltd. in 2017, SYGNIS significantly expanded its product line and now covers the entire molecular biology workflow, including genomics, proteomics and tools as well as cutting-edge bioconjugation technologies and services. SYGNIS' products are sold through a direct sales force and several distribution partners in Europe, the U.S. and Asia. The SYGNIS Group has offices in Germany, Spain and the UK; production sites in the UK and the U.S. and sales offices in Asia. The Company is listed on the Prime Standard segment of the Frankfurt Stock Exchange (Ticker: LIO1; ISIN: DE000A1RFM03). *

 

Period Start 2013-10-28 renamed before
  Group Expedeon (Group)
  Predecessor Sygnis Pharma AG
Products Industry Qualiphi® DNA polymerase
  Industry 2 Next Generation Sequencing (NGS) technology [about 2007/8]
Person Person de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia)
     
Region Region Heidelberg
  Country Germany
  Street 515 Im Neuenheimer Feld
  City 69120 Heidelberg
    Address record changed: 2013-10-30
     
Basic data Employees B: 11 to 50 (2014-11-11)
  Currency EUR
  Annual sales 1,789,000 (revenues (2016) 2016-12-31)
  Profit -4,388,000 (2015-12-31)
  Cash 3,795,000 (2016-12-31)
     
    * Document for �About Section�: Sygnis AG. (10/18/17). "Press Release: Sygnis AG Announces Completion of Relocation of Its Innova Biosciences Unit to Allow for Expansion". Madrid & Heidelberg.
     
   
Record changed: 2019-11-20

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Expedeon (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top